Moderna (MRNA) Capital Leases (2017 - 2026)
Moderna (MRNA) posted Capital Leases of $6 million for Q2 2026, down 81.3% from $32 million a year earlier and down 53.8% from the prior quarter.
Analysis
Moderna (MRNA) Capital Leases (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna's Capital Leases came in at $20 million, down 48.7% from FY2024.
- Annual Capital Leases has declined for three consecutive years, with a five-year compound annual growth rate of -28.9% (FY2020 to FY2025).
- In prior years, Moderna's Capital Leases was $39 million in FY2024 (-93.2%), $575 million in FY2023 (-37.0%), $912 million in FY2022 (+52.3%) and $599 million in FY2021 (+444.5%).
- The Q2 2026 figure stands as the lowest quarterly Capital Leases in data going back to Q4 2017.
- On a year-over-year basis, Capital Leases has declined in each of the last seven quarters, with an average decline of 70.2% over the last eight quarters.
- The strongest year-over-year quarter for Capital Leases in the past five years was Q4 2021, with growth of 444.5%; the weakest was Q3 2025, with a decline of 95.8%.
- According to Business Quant data, Capital Leases for the three prior quarters was $13 million (Q1 2026), $20 million (Q4 2025) and $26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 20.00 Mn |
| Sep 30, 2025 | 26.00 Mn |
| Jun 30, 2025 | 32.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 39.00 Mn |
| Sep 30, 2024 | 625.00 Mn |
| Jun 30, 2024 | 576.00 Mn |
| Mar 31, 2024 | 575.00 Mn |
| Dec 31, 2023 | 575.00 Mn |
| Sep 30, 2023 | 575.00 Mn |
| Jun 30, 2023 | 843.00 Mn |
| Mar 31, 2023 | 831.00 Mn |
| Dec 31, 2022 | 912.00 Mn |
| Sep 30, 2022 | 922.00 Mn |
| Jun 30, 2022 | 641.00 Mn |
| Mar 31, 2022 | 646.00 Mn |
| Dec 31, 2021 | 599.00 Mn |
| Sep 30, 2021 | 238.00 Mn |
API Access
Moderna Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();